跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XIMLUCI 10 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
XIMLUCI 10 MG/ML SOLUCION INYECTABLE
Approved
STANDARD
XIMLUCI 10 MG/ML SOLUCION INYECTABLE
Stada Arzneimittel Ag
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 22, 2022
Approval ID
4a2ca03e0e301b7d
Company
Stada Arzneimittel Ag
Type
Standard
Approval Details
Approval Id
4a2ca03e0e301b7d
Drug Cima Aemps Name
XIMLUCI 10 MG/ML SOLUCION INYECTABLE
Register Number
1221691001
Holder Company Name
Stada Arzneimittel Ag
Marketing Company Name
Laboratorio Stada S.L.
Holder Company Detail Path
/organization/stada-arzneimittel-ag
Authorization Date
2022-11-22
Dosage Form
SOLUCIÓN INYECTABLE
Dose
10 MG/ML
Route Of Administration
VÍA INTRAVÍTREA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Stada Arzneimittel Ag
Company Detail Path
/organization/stada-arzneimittel-ag
Company Information
Pharmaceutical Company Name
STADA Arzneimittel AG
Country Name
Germany
Website
http://www.stada.com
Active Ingredients
RANIBIZUMAB
2,3 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 22, 2022
Approval ID
4a2ca03e0e301b7d
Type
Standard
Back to CIMA-AEMPS Approvals